In vivo models for early development of colorectal liver metastasis

International Journal of Experimental Pathology

Volumn 89, Issue 1, 2008, Pages 1-12

  Robertson, John H P ^a   Sarkar, Sandip ^a   Yang, Shi Yu ^a   Seifalian, Alexander M ^a   Winslet, Marc C ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Experimental model; Intravital videomicroscopy; Metastasis

Indexed keywords

CALCEIN; CD133 ANTIGEN; FLUORESCENT DYE;

CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL PROLIFERATION; COLORECTAL LIVER METASTASIS; EXPERIMENTAL MODEL; HOMEOSTASIS; HUMAN; INTERVENTION STUDY; INTRAVITAL VIDEOMICROSCOPY; LABELING INDEX; MARKER GENE; METASTASIS; MICROENVIRONMENT; MICROSCOPY; ORGAN DONOR; PREVALENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SURGICAL TECHNIQUE; TUMOR CELL;

EID: 38049119929     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2007.00562.x     Document Type: Review

References (55)

1. Allegra C. Sargent D.J. (2005) Adjuvant therapy for colon cancer - the pace quickens. N. Engl. J. Med. 352, 2746 2748.
2. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., Muschel R.J. (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6, 100 102.
3. Bao S, Wu Q, McLendon R.E. et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756 760.
4. Boyle P. Ferlay J. (2005) Cancer incidence and mortality in Europe, 2004. Ann. Oncol. 16, 481 488.
5. Chalfie M, Tu Y, Euskirchen G. et al. (1994) Green fluorescent protein as a marker for gene expression. Science 263, 802 805.
6. Chambers A.F., Naumov G.N., Varghese H.J., Nadkarni K.V., MacDonald I.C., Groom A.C. (2001) Critical steps in hematogenous metastasis: an overview. Surg. Oncol. Clin. N. Am. 10, 563 572.
7. Chambers A.F., Groom A.C., MacDonald I.C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563 572.
8. Chen J., Tung C.H., Mahmood U. et al. (2002) In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105, 2766 2771.
9. Cheng L., Fu J., Tsukamoto A. et al. (1996) Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat. Biotechnol. 14, 606 609.
10. Chester K., Pedley B., Tolner B. et al. (2004) Engineering antibodies for clinical applications in cancer. Tumour Biol. 25, 91 98.
11. Cormack B.P., Valdivia R.H., Falkow S., Cormack B.P., Valdivia R.H., Falkow S. (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173, 33 38.
12. Ding L., Sunamura M., Kodama T. et al. (2001) In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells. Br. J. Cancer 85, 431 438.
13. Domino S.E., Karnak D.M., Hurd E.A., Domino S.E., Karnak D.M., Hurd E.A. (2007) Cell surface fucosylation does not affect development of colon tumors in mice with germline Smad3 mutation. Tumour Biol. 28, 77 83.
14. Eble J.A., Haier J., Eble J.A., Haier J. (2006) Integrins in cancer treatment. Curr. Cancer Drug Targets 6, 89 105.
15. Enns A., Gassmann P., Schluter K. et al. (2004) Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J. Gastrointest. Surg. 8, 1049 1059.
16. Enns A., Korb T., Schluter K. et al. (2005) Avbeta5-integrins mediate early steps of metastasis formation. Eur. J. Cancer 41, 1065 1072.
17. Fidler I.J. (2002) The organ microenvironment and cancer metastasis. Differentiation 70, 498 505.
18. Fidler I.J. (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453 458.
19. Figueiredo J.L., Alencar H., Weissleder R. et al. (2006) Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int. J. Cancer 118, 2672 2677.
20. Flatmark K., Maelandsmo G.M., Martinsen M., Rasmussen H., Fodstad O. (2004) Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur. J. Cancer 40, 1593 1598.
21. Guilbaud N., Kraus-Berthier L., Meyer-Losic F. et al. (2001) Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors. Clin. Cancer Res. 7, 2573 2580.
22. Haier J., Nasralla M., Nicolson G.L. (1999) Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components. Br. J. Cancer 80, 1867 1874.
23. Haier J., Korb T., Hotz B., Spiegel H-U., Senninger N. (2003) An intravital model to monitor steps of metastatic tumour cell adhesion within the hepatic microcirculation. J. Gastrointest. Surg. 7, 507 515.
24. Hoffman R. (2002) Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol. 3, 546 556.
25. Iga A.M., Sarkar S., Sales K.M., Winslet M.C., Seifalian A.M. (2006) Quantitating therapeutic disruption of tumour blood flow with intravital video microscopy. Cancer Res. 66, 11517 11519.
26. Ito S., Nakanishi H., Ikehara Y. et al. (2001) Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. Int. J. Cancer 93, 212 217.
27. Kavolius J., Fong Y., Blumgart L.H. (1996) Surgical resection of metastatic liver tumors. Surg. Oncol. Clin. N. Am. 5, 337 352.
28. Kikkawa H., Kaihou M., Horaguchi N. et al. (2002) Role of integrin alpha (v)beta3 in the early phase of liver metastasis: PET and IVM analyses. Clin. Exp. Metastasis 19, 717 725.
29. Koop S., MacDonald I.C., Luzzi K. et al. (1995) Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res. 55, 2520 2523.
30. Lin W.C. Culp L.A. (1991) Selectable plasmid vectors with alternative and ultrasensitive histochemical marker genes. Biotechniques 11, 344 348, 350-351.
31. Lin W.C., Pretlow T.P., Pretlow T.G. et al. (1990) Bacterial LacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res. 50, 2808 2817.
32. Liotta L.A., Kohn E.C. (2001) The microenvironment of the tumour-host interface. [Review] [65 Refs]. Nature 411, 375 379.
33. Luzzi K.J., MacDonald I.C., Schmidt E.E. et al. (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865 873.
34. MacDonald I.C., Groom A.C., Chambers A.F. (2002) Cancer spread and micrometastasis development: quantitative approaches for in vivo models. Bioessays 24, 885 893.
35. Mutsaerts E.L., van R.S., Zoetmulder F.A., Rutgers E.J., Hart A.A., van C.F. (2005) Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. J. Gastrointest. Surg. 9, 178 186.
36. Naumov G.N., Wilson S.M., MacDonald I.C. et al. (1999) Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J. Cell Sci. 112, 1835 1842.
37. Nelson H., Petrelli N., Carlin A. et al. (2001) Guidelines 2000 for colon and rectal cancer surgery. J. Natl Cancer Inst. 93, 583 596.
38. O'Brien C.A., Pollett A., Gallinger S. et al. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106 110.
39. Onn A., Fidler I.J. (2002) Metastatic potential of human neoplasms. In Vivo 16, 423 429.
40. Paget S. (1889) The distribution of secondary growths in cancer of the breast. Lancet 1, 571 573.
41. Parkin D.M., Bray F., Ferlay J., Pisani P. (2001) Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94, 153 156.
42. Philipp-Staheli J., Kim K.H., Payne S.R. et al. (2002) Pathway-specific tumor suppression. reduction of P27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 1, 355 368.
43. Reinmuth N., Liu W., Ahmad S.A. et al. (2003) Alphavbeta3 integrin antagonist s247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res. 63, 2079 2087.
44. Scheele J., Stang R., tendorf-Hofmann A., Paul M. (1995) Resection of colorectal liver metastases. World J. Surg. 19, 59 71.
45. Schluter K., Gassmann P., Enns A. et al. (2006) Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am. J. Pathol. 169, 1064 1073.
46. Steinbauer M., Guba M., Cernaianu G. et al. (2003) GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice. Clin. Exp. Metastasis 20, 135 141.
47. Sturm J.W., Keese M.A., Petruch B. et al. (2003) Enhanced green fluorescent protein-transfection of murine colon carcinoma cells: key for early tumor detection and quantification. Clin. Exp. Metastasis 20, 395 405.
48. Sweeney T.J., Mailander V., Tucker A.A. et al. (1999) Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl Acad. Sci. USA 96, 12044 12049.
49. Tung C.H., Mahmood U., Bredow S. et al. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60, 4953 4958.
50. Tung C.H., Zeng Q., Shah K. et al. (2004) In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res. 64, 1579 1583.
51. Twelves C., Wong A., Nowacki M.P. et al. (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N. Engl. J. Med. 352, 2696 2704.
52. Uggeri J., Gatti R., Belletti S. et al. (2004) Calcein-AM is a detector of intracellular oxidative activity. Histochem. Cell Biol. 122, 499 505.
53. Weissleder R., Tung C.H., Mahmood U. et al. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375 378.
54. Zhu Y., Richardson J.A., Parada L.F. et al. (1998) Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703 714.
55. Zolotukhin S., Potter M., Hauswirth W.W. et al. (1996) A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70, 4646 4654.